8 Feb

Record French damages award is a good sign for pharma patentees

A recent preliminary ruling in Eli Lilly’s favour demonstrates a trend towards a more balanced approach to injunctions and damages on the part of the Paris Patent Court, write Benoit Strowel, Florence Jacquand and Charles Bouthier of Hoyng Rokh Monegier